Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
105,863,294
-
Total 13F shares
-
73,847,277
-
Share change
-
+4,151,439
-
Total reported value
-
$1,424,958,805
-
Put/Call ratio
-
60%
-
Price per share
-
$19.30
-
Number of holders
-
186
-
Value change
-
+$85,438,923
-
Number of buys
-
110
-
Number of sells
-
58
Institutional Holders of CORCEPT THERAPEUTICS INC - Common Stock (CORT) as of Q3 2017
As of 30 Sep 2017,
CORCEPT THERAPEUTICS INC - Common Stock (CORT) was held by
186 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
73,847,277 shares.
The largest 10 holders included
FEDERATED INVESTORS INC /PA/, BlackRock Inc., INGALLS & SNYDER LLC, VANGUARD GROUP INC, Consonance Capital Management LP, RENAISSANCE TECHNOLOGIES LLC, ACADIAN ASSET MANAGEMENT LLC, Invesco Ltd., STATE STREET CORP, and DIMENSIONAL FUND ADVISORS LP.
This page lists
187
institutional shareholders reporting positions in this security
for the Q3 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.